Cumberland Pharmaceuticals Inc
NASDAQ:CPIX

Watchlist Manager
Cumberland Pharmaceuticals Inc Logo
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Watchlist
Price: 4.41 USD 0.68% Market Closed
Market Cap: 66m USD

Relative Value

The Relative Value of one CPIX stock under the Base Case scenario is 2.59 USD. Compared to the current market price of 4.41 USD, Cumberland Pharmaceuticals Inc is Overvalued by 41%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CPIX Relative Value
Base Case
2.59 USD
Overvaluation 41%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
9
vs Industry
57
Median 3Y
0.7
Median 5Y
0.9
Industry
2.6
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-8.5
Industry
21.7
vs History
9
vs Industry
48
Median 3Y
3.9
Median 5Y
6.4
Industry
16.7
vs History
vs Industry
10
Median 3Y
9.9
Median 5Y
9.9
Industry
23.1
vs History
4
vs Industry
28
Median 3Y
0.9
Median 5Y
0.9
Industry
2.2
vs History
7
vs Industry
63
Median 3Y
0.6
Median 5Y
0.8
Industry
2.9
vs History
9
vs Industry
73
Median 3Y
0.8
Median 5Y
1
Industry
5.5
vs History
12
vs Industry
5
Median 3Y
-2
Median 5Y
-3.2
Industry
13.2
vs History
vs Industry
Median 3Y
-4
Median 5Y
-5.5
Industry
16.8
vs History
14
vs Industry
47
Median 3Y
3.4
Median 5Y
5
Industry
15.9
vs History
23
vs Industry
35
Median 3Y
4.1
Median 5Y
5.5
Industry
19.2
vs History
3
vs Industry
50
Median 3Y
0.5
Median 5Y
0.6
Industry
1.9

Multiples Across Competitors

CPIX Competitors Multiples
Cumberland Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
66m USD 1.6 -19.8 116.3 -17.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55 36.9 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
496.6B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
259.2B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.2 108.4 158.6
CH
Novartis AG
SIX:NOVN
208.2B CHF 4.7 18.2 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.4B USD 3.9 13.2 9.4 11.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
US
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Average P/E: 24
Negative Multiple: -19.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Average EV/EBITDA: 409.5
116.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Average EV/EBIT: 1 881.3
Negative Multiple: -17.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.2
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3